Phase II Study of Vinflunine in Malignant Pleural Mesothelioma
Vinflunine shows encouragin sings for treatment in Malignant Pleural Mesothelioma.
Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM.
Patients and Methods: Patients with a histologically confirmed diagnosis of